Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia

American Journal of Hematology · Published 2026-07-28 · DOI 10.1002/ajh.70452

Free full text

Authors (20)

Lubna Osman‐Kardash, Ahmed Alnajar, Anthony D. Anderson, Ellen Madarang, Mikkael A. Sekeres, Justin Watts, Terrence Bradley, Wenhui Li, Jill Lykon, Mohammed Raja, Antonio Jimenez Jimenez, Amer Beitinjaneh, Trent Wang, Mark Goodman, Lazaros Lekakis, Jay Spiegel, Noa G. Holtzman, Denise Pereira, Damian Green, Jose F. Camargo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Osman‐Kardash, L., Alnajar, A., Anderson, A., et al. (2026). Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.70452

Related articles

• Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management · American Journal of Hematology · 2026 · Same journal
• Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T‐Cell Lymphoma · American Journal of Hematology · 2026 · Same journal
• Intensive Induction in AML in the Era of Venetoclax: A Standing Count for “7 + 3”? · American Journal of Hematology · 2026 · Same journal
• ICC / WHO ‐Defined and NGS ‐Annotated Idiopathic Hypereosinophilia ( iHES / iHE ): Mutations, Clinical and Treatment Details, and Predictors of Survival · American Journal of Hematology · 2026 · Same journal
• Promoter TERT ‐ Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders · American Journal of Hematology · 2026 · Same journal
• Mosaic Chromosomal Alterations Identify Ultra‐High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy · American Journal of Hematology · 2026 · Same journal
• A New Fetal Hemoglobin‐Related Phenotype in Sickle Cell Anemia · American Journal of Hematology · 2026 · Same journal
• p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53 ‐Mutated Cases · American Journal of Hematology · 2026 · Same journal
• Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma · American Journal of Hematology · 2026 · Same journal
• Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B‐ ALL · American Journal of Hematology · 2026 · Same journal